Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-04-27 Sale | 2020-04-28 1:43 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 145 | $24.35 | $3,531 | 13,001 (Direct) | View |
| 2020-02-14 Sale | 2020-02-18 2:33 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 612 | $28.04 | $17,160 | 16,849 (Direct) | View |
| 2020-01-27 Sale | 2020-01-28 5:14 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 684 | $29.26 | $20,014 | 11,999 (Direct) | View |
| 2019-11-14 Sale | 2019-11-18 4:04 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 608 | $26 | $15,806 | 16,479 (Direct) | View |
| 2019-08-15 Sale | 2019-08-16 3:38 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 608 | $31.65 | $19,243 | 17,087 (Direct) | View |
| 2019-05-14 Sale | 2019-05-16 6:20 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 608 | $37.98 | $23,092 | 17,695 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-04-26 Exercise | 2020-04-28 1:43 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 417 | $0 | 13,001 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 2:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 1,759 | $0 | 16,849 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:39 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 18,000 | $0 | 18,000 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:14 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 1,666 | $0 | 11,999 (Direct) | View |
| 2019-11-14 Exercise | 2019-11-18 4:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 1,759 | $0 | 16,479 (Direct) | View |
| 2019-08-14 Exercise | 2019-08-16 3:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 1,759 | $0 | 17,087 (Direct) | View |
| 2019-05-14 Exercise | 2019-05-16 6:20 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen Chief Operating Officer | 1,759 | $0 | 17,695 (Direct) | View |